4//SEC Filing
Machatha Stephen 4
Accession 0000899243-22-013173
CIK 0001341235other
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 7:37 PM ET
Size
8.7 KB
Accession
0000899243-22-013173
Insider Transaction Report
Form 4
Machatha Stephen
Chief Development Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-03-30+250,000→ 250,000 totalExercise: $4.52Exp: 2032-03-29→ Common Stock (250,000 underlying) - Award
Common Stock
2022-03-30+64,395→ 87,658 total
Holdings
- 211(indirect: See Footnote)
Common Stock
Footnotes (4)
- [F1]Represents shares of common stock underlying a time-based restricted stock unit award (RSU). The RSU vests ratably in equal annual installments over a four-year period beginning on January 1, 2022, provided that the Reporting Person has provided continuous service to the Issuer through the applicable vesting date.
- [F2]Includes 2,972 shares previously purchased under the Issuer's Employee Stock Purchase Plan.
- [F3]These shares are held directly by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership over these shares for purposes of Section 16 or for any other purposes.
- [F4]The shares subject to this option shall vest in equal monthly installments over the next 48 months of continuous service to the Issuer after January 1, 2022.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeother
Related Parties
1- filerCIK 0001836354
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 7:37 PM ET
- Size
- 8.7 KB